โ† All Topics / ade

FDA ADE reports for Canine Parvovirus Monoclonal Antibody

ade_canine_parvovirus_monoclonal_antibody_adverse_events

ade en 2026-07-22

Canine Parvovirus Monoclonal Antibody โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Canine Parvovirus Monoclonal Antibody is a active ingredient.

Total reports

Canine Parvovirus Monoclonal Antibody: 67

Reports by species (top entries)

  • Dog 67

Top reported reactions (VEDDRA terms, top entries)

  • Death 27
  • Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 26
  • Lethargy (see also Central nervous system depression in Neurological) 13
  • Diarrhoea 10
  • Not eating 10
  • Vomiting 10
  • Death by euthanasia 9
  • Other abnormal test result NOS 9
  • Leucocytosis NOS 7
  • Agonal breathing 6

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b23.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).